DiscGenics Study Updates: Injectable Discogenic Cell Therapy
The company has completed enrollment in its Japanese safety study of allogeneic, injectable discogenic cell therapy for lumbar disc degeneration....
The company has completed enrollment in its Japanese safety study of allogeneic, injectable discogenic cell therapy for lumbar disc degeneration....
The company's foot and ankle business continued its steady growth in FY 3Q21, offsetting some impact from COVID's third wave...
The move is another step in DJO's strategic entry into the estimated $1 billion foot and ankle market that is...
With FDA clearance for patient-specific instrumentation, Conformis achieved its 3rd milestone and will receive $11 million from Stryker....
Awl-in-One Tap is a single-use spinal surgery instrument with a disposable neuromonitoring EMG system and digital depth measurement built in....
The OTS platform is assisted by AI for accuracy and efficiency. The current module is a pre-operative planning solution for...
Often, when a business reaches a certain level of maturity leadership begins to think about expansion beyond their original products...
Mr. Lin has led the U.S. operations for United Orthopedic for more than a decade. He has learned that trust...
The system expands the line of PEEK, PTC and now titanium interbody offerings from Orthofix for transforaminal lumbar applications....
These companies recently received notable FDA 510(k) clearances, funding or launched products and studies. We highlight robotics/digital, spine and orthobiologic...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.